AbstractThe global pharmaceutical supply chain, a complex system, involves manufacturing, distribution, and commercial wholesale/retail processes. Products in this system‐of‐systems are critical to health, subject to regulation from a web of trans‐national, national, and state/provincial authorities, and subject to commercial manufacturing, marketing, and distribution practices of numerous enterprises. Introductions of change into this environment is a challenging undertaking, demanding awareness of the many forms of and constraints upon this system, while delivering at the brisk rate required by law and commerce. For example, in response to drug counterfeiting and grey markets, national and local governments are currently introducing (differing) legal requirements to uniquely label and track pharmaceutical products to the individual retail bottle/package level, as they move through distribution. This paper describes the response of a global pharmaceutical manufacturer, re‐engineering multiple global product and country‐unique pharmaceutical product packaging lines, using Systems Engineering Patterns to reduce impacts of variable requirement and design configurations.
Read full abstract